These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23643146)

  • 1. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
    Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
    Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
    Canas PM; Simões AP; Rodrigues RJ; Cunha RA
    Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.
    Sokolow S; Luu SH; Nandy K; Miller CA; Vinters HV; Poon WW; Gylys KH
    Neurobiol Dis; 2012 Jan; 45(1):381-7. PubMed ID: 21914482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.
    Amorim JA; Canas PM; Tomé AR; Rolo AP; Agostinho P; Palmeira CM; Cunha RA
    J Alzheimers Dis; 2017; 60(2):525-536. PubMed ID: 28869472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.
    Timmer NM; Metaxas A; van der Stelt I; Kluijtmans LA; van Berckel BN; Verbeek MM
    J Alzheimers Dis; 2014; 39(1):89-101. PubMed ID: 24145381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
    Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
    J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's disease.
    Schallier A; Smolders I; Van Dam D; Loyens E; De Deyn PP; Michotte A; Michotte Y; Massie A
    J Alzheimers Dis; 2011; 24(2):287-300. PubMed ID: 21297271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.
    Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R
    J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells.
    León-Espinosa G; DeFelipe J; Muñoz A
    J Alzheimers Dis; 2012; 29(4):841-52. PubMed ID: 22337828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.
    Liu LZ; Fan SJ; Gao JX; Li WB; Xian XH
    Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
    Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
    Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
    Duffy AM; Hölscher C
    Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.
    Garcia-Garcia AL; Elizalde N; Matrov D; Harro J; Wojcik SM; Venzala E; Ramírez MJ; Del Rio J; Tordera RM
    Biol Psychiatry; 2009 Aug; 66(3):275-82. PubMed ID: 19409534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice.
    Woodhouse A; Fernandez-Martos CM; Atkinson RAK; Hanson KA; Collins JM; O'Mara AR; Terblanche N; Skinner MW; Vickers JC; King AE
    BMC Anesthesiol; 2018 Apr; 18(1):47. PubMed ID: 29699479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.
    Rodriguez-Perdigon M; Tordera RM; Gil-Bea FJ; Gerenu G; Ramirez MJ; Solas M
    Hippocampus; 2016 Oct; 26(10):1303-12. PubMed ID: 27258819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.